Total Payments
$7,973
2024 Payments
$416.05
Companies
26
Transactions
196
Medicare Patients
6,504
Medicare Billing
$913,026
Payment Breakdown by Category
Food & Beverage$4,842 (60.7%)
Travel$1,626 (20.4%)
Consulting$1,500 (18.8%)
Education$4.78 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,842 | 187 | 60.7% |
| Travel and Lodging | $1,626 | 7 | 20.4% |
| Consulting Fee | $1,500 | 1 | 18.8% |
| Education | $4.78 | 1 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Nutech Spine, Inc. | $2,166 | 2 | $0 (2020) |
| Abbott Laboratories | $1,470 | 78 | $0 (2024) |
| Vertiflex, Inc. | $1,072 | 12 | $0 (2019) |
| Relievant Medsystems, Inc. | $840.39 | 8 | $0 (2022) |
| Spinal Simplicity, LLC | $536.20 | 7 | $0 (2022) |
| BOSTON SCIENTIFIC CORPORATION | $425.87 | 26 | $0 (2022) |
| Vertos Medical, Inc. | $332.39 | 9 | $0 (2024) |
| AbbVie Inc. | $239.63 | 16 | $0 (2023) |
| SI-BONE, INC. | $212.66 | 3 | $0 (2024) |
| Collegium Pharmaceutical, Inc. | $140.91 | 7 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $416.05 | 14 | SI-BONE, INC. ($190.93) |
| 2023 | $374.16 | 23 | AbbVie Inc. ($181.43) |
| 2022 | $2,045 | 45 | Relievant Medsystems, Inc. ($840.39) |
| 2021 | $691.55 | 47 | Abbott Laboratories ($258.86) |
| 2020 | $1,843 | 22 | Nutech Spine, Inc. ($1,500) |
| 2019 | $397.43 | 14 | Abbott Laboratories ($279.02) |
| 2018 | $1,858 | 21 | Vertiflex, Inc. ($968.72) |
| 2017 | $348.31 | 10 | Abbott Laboratories ($323.10) |
All Payment Transactions
196 individual payment records from CMS Open Payments — Page 1 of 8
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/23/2024 | Abbott Laboratories | ETERNA (Device) | Food and Beverage | In-kind items and services | $16.07 | General |
| Category: Neuromodulation | ||||||
| 10/08/2024 | Abbott Laboratories | ETERNA (Device) | Food and Beverage | In-kind items and services | $13.90 | General |
| Category: Neuromodulation | ||||||
| 10/04/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $21.52 | General |
| Category: Gastroenterology | ||||||
| 09/20/2024 | Abbott Laboratories | ETERNA (Device) | Food and Beverage | In-kind items and services | $18.62 | General |
| Category: Neuromodulation | ||||||
| 08/20/2024 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $22.13 | General |
| Category: Opioid Analgesic | ||||||
| 07/15/2024 | Abbott Laboratories | PROCLAIM (Device) | Food and Beverage | In-kind items and services | $14.54 | General |
| Category: Neuromodulation | ||||||
| 06/11/2024 | Nevro Corp. | Senza (Device) | Food and Beverage | In-kind items and services | $21.45 | General |
| Category: Spinal Cord Stimulator | ||||||
| 06/04/2024 | SI-BONE, INC. | — | Food and Beverage | Cash or cash equivalent | $44.21 | General |
| 05/30/2024 | SI-BONE, INC. | — | Food and Beverage | Cash or cash equivalent | $146.72 | General |
| 04/16/2024 | Vertos Medical, Inc. | mild Device Kit (Device) | Food and Beverage | In-kind items and services | $18.19 | General |
| Category: Orthopedic | ||||||
| 04/02/2024 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $20.99 | General |
| Category: Opioid Analgesic | ||||||
| 02/22/2024 | Collegium Pharmaceutical, Inc. | Belbuca (Drug) | Food and Beverage | Cash or cash equivalent | $22.27 | General |
| Category: Opioid Analgesic | ||||||
| 02/21/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | RELISTOR (Drug) | Food and Beverage | In-kind items and services | $21.76 | General |
| Category: Gastroenterology | ||||||
| 01/03/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | RELISTOR (Drug) | Food and Beverage | In-kind items and services | $13.68 | General |
| Category: Gastroenterology | ||||||
| 12/23/2023 | Abbott Laboratories | PROCLAIM (Device) | Food and Beverage | In-kind items and services | $14.73 | General |
| Category: Neuromodulation | ||||||
| 11/30/2023 | AbbVie Inc. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $24.00 | General |
| Category: NEUROSCIENCE | ||||||
| 11/18/2023 | SI-BONE, INC. | — | Food and Beverage | Cash or cash equivalent | $21.73 | General |
| 11/06/2023 | AbbVie Inc. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $3.74 | General |
| Category: NEUROSCIENCE | ||||||
| 11/01/2023 | AbbVie Inc. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $20.58 | General |
| Category: NEUROSCIENCE | ||||||
| 09/12/2023 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $18.18 | General |
| Category: Obesity | ||||||
| 09/06/2023 | Abbott Laboratories | PROCLAIM (Device) | Food and Beverage | In-kind items and services | $17.50 | General |
| Category: Neuromodulation | ||||||
| 08/24/2023 | AbbVie Inc. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $22.07 | General |
| Category: NEUROSCIENCE | ||||||
| 08/22/2023 | Abbott Laboratories | PROCLAIM (Device) | Food and Beverage | In-kind items and services | $17.40 | General |
| Category: Neuromodulation | ||||||
| 08/16/2023 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $3.57 | General |
| Category: NEUROSCIENCE | ||||||
| 08/07/2023 | Bioventus LLC | Durolane (Device) | Food and Beverage | In-kind items and services | $18.81 | General |
| Category: Orthopedics/Orthopedic Surgery | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 26 | 1,431 | 5,583 | $1.1M | $206,245 |
| 2022 | 28 | 1,545 | 6,210 | $1.3M | $232,292 |
| 2021 | 27 | 1,846 | 8,692 | $1.5M | $260,504 |
| 2020 | 25 | 1,682 | 8,653 | $1.4M | $213,985 |
Total Patients
6,504
Total Services
29,138
Medicare Billing
$913,026
Procedure Codes
106
All Medicare Procedures & Services
106 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| G0482 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | Office | 2023 | 137 | 221 | $146,744 | $41,852 | 28.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 145 | 348 | $88,044 | $30,476 | 34.6% |
| G3002 | Chronic pain management and treatment, monthly bundle including, diagnosis; assessment and monitoring; administration of a validated pain rating scale or tool; the development, implementation, revision, and/or maintenance of a person-centered care plan tha | Office | 2023 | 170 | 453 | $139,071 | $25,618 | 18.4% |
| 64483 | Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | Office | 2023 | 41 | 61 | $113,043 | $13,158 | 11.6% |
| 80307 | Testing for presence of drug, by chemistry analyzers | Office | 2023 | 139 | 225 | $56,025 | $13,113 | 23.4% |
| J3304 | Injection, triamcinolone acetonide, preservative-free, extended-release, microsphere formulation, 1 mg | Office | 2023 | 11 | 832 | $62,400 | $10,974 | 17.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 98 | 147 | $26,166 | $8,948 | 34.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 57 | 57 | $18,715 | $6,442 | 34.4% |
| 27096 | Injection of anesthetic or steroid into joint between lower spine and hip bone using imaging guidance | Office | 2023 | 34 | 48 | $55,278 | $6,396 | 11.6% |
| 64635 | Destruction of lower or sacral spinal facet joint nerves using imaging guidance, single facet joint | Office | 2023 | 13 | 14 | $34,860 | $6,107 | 17.5% |
| 64493 | Injection of lower or sacral spine facet joint using imaging guidance, single level | Office | 2023 | 23 | 33 | $77,164 | $5,838 | 7.6% |
| 64490 | Injection of upper or middle spine facet joint using imaging guidance, single level | Office | 2023 | 21 | 29 | $61,918 | $5,670 | 9.2% |
| 64633 | Destruction of upper or middle spinal facet joint nerves using imaging guidance, single facet joint | Office | 2023 | 12 | 12 | $31,006 | $5,660 | 18.3% |
| 20611 | Aspiration and/or injection of fluid large joint using ultrasound guidance | Office | 2023 | 31 | 54 | $23,546 | $4,180 | 17.8% |
| 64634 | Destruction of upper or middle spinal facet joint nerves using imaging guidance, each additional facet joint | Office | 2023 | 12 | 12 | $13,986 | $3,426 | 24.5% |
| 64484 | Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, each additional level | Office | 2023 | 28 | 40 | $35,560 | $3,363 | 9.5% |
| 64636 | Destruction of lower or sacral spinal facet joint nerves using imaging guidance, each additional facet joint | Office | 2023 | 12 | 13 | $13,167 | $3,311 | 25.1% |
| 64494 | Injection of lower or sacral spine facet joint using imaging guidance, second level | Office | 2023 | 22 | 32 | $29,694 | $3,173 | 10.7% |
| 64491 | Injection of upper or middle spine facet joint using imaging guidance, second level | Office | 2023 | 20 | 28 | $26,760 | $2,771 | 10.4% |
| 62321 | Injection of substance into middle or upper spine canal using imaging guidance | Office | 2023 | 12 | 13 | $21,593 | $2,220 | 10.3% |
| J1030 | Injection, methylprednisolone acetate, 40 mg | Office | 2023 | 105 | 315 | $15,120 | $1,878 | 12.4% |
| 20553 | Injection of trigger points, 3 or more muscles | Office | 2023 | 20 | 26 | $8,892 | $1,120 | 12.6% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 58 | 408 | $2,448 | $338.21 | 13.8% |
| J2704 | Injection, propofol, 10 mg | Office | 2023 | 94 | 1,593 | $1,593 | $143.98 | 9.0% |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | Office | 2023 | 89 | 504 | $504.00 | $61.13 | 12.1% |
About Dr. John Williamson, M.D
Dr. John Williamson, M.D is a Pain Medicine healthcare provider based in Huntsville, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/29/2006. The National Provider Identifier (NPI) number assigned to this provider is 1922069186.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. John Williamson, M.D has received a total of $7,973 in payments from pharmaceutical and medical device companies, with $416.05 received in 2024. These payments were reported across 196 transactions from 26 companies. The most common payment nature is "Food and Beverage" ($4,842).
As a Medicare-enrolled provider, Williamson has provided services to 6,504 Medicare beneficiaries, totaling 29,138 services with total Medicare billing of $913,026. Data is available for 4 years (2020–2023), covering 106 distinct procedure/service records.
Ad
Practice Information
- Specialty Pain Medicine
- Location Huntsville, TX
- Active Since 03/29/2006
- Last Updated 12/11/2019
- Taxonomy Code 208VP0000X
- Entity Type Individual
- NPI Number 1922069186
Products in Payments
- Superion ISS (Device) $1,072
- Intracept (Device) $840.39
- SIFIX (Device) $666.23
- HA MINUTEMAN G3-R (Device) $536.20
- Proclaim Family of SCS IPGs (Device) $464.40
- mild Device Kit (Device) $332.39
- Superion (Device) $257.93
- Proclaim IPG (Device) $239.38
- DRG IPGs (Device) $225.10
- Superion Indirect Decompression System (Device) $167.94
- PROCLAIM (Device) $159.69
- UBRELVY (Drug) $121.07
- XTAMPZA (Drug) $118.64
- QULIPTA (Drug) $118.56
- Radiofrequency Therapy (Device) $98.66
- XIFAXAN (Drug) $89.87
- Axium INS DRG IPG (Device) $89.62
- Prodigy Family of SCS IPGs (Device) $71.44
- RELISTOR (Drug) $50.92
- ETERNA (Device) $48.59
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Pain Medicine Doctors in Huntsville
Dr. James Thacker, M.d, M.D
Pain Medicine — Payments: $39,442
Pain Medicine $39,442
Anisa Gopalani, M.d, M.D
Pain Medicine — Payments: $33,827
Pain Medicine $33,827
Stephen Sims, Md, MD
Pain Medicine — Payments: $23,067
Pain Medicine $23,067
John Roberts, Md, MD
Pain Medicine — Payments: $7,205
Pain Medicine $7,205
Victor Chin, Md, MD
Pain Medicine — Payments: $3,742
Pain Medicine $3,742
Thomas Kraus, Do, DO
Pain Medicine — Payments: $2,311
Pain Medicine $2,311